Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 2
2006 1
2007 1
2009 1
2010 1
2012 15
2013 122
2014 2180
2015 15877
2016 2360
2017 129
2018 7
2019 1
2020 1
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

15,877 results
Results by year
Filters applied: . Clear all
Page 1
Genetic diagnosis and prognosis of Alzheimer's disease: challenges and opportunities.
Reitz C. Reitz C. Expert Rev Mol Diagn. 2015 Mar;15(3):339-48. doi: 10.1586/14737159.2015.1002469. Epub 2015 Jan 29. Expert Rev Mol Diagn. 2015. PMID: 25634383 Free PMC article. Review.
Alzheimer's disease (AD), the most common form of dementia in western societies, is a pathologically and clinically heterogeneous disease with a strong genetic component. ...During the last 5 years, genome-wide association and whole-exome- and w
Alzheimer's disease (AD), the most common form of dementia in western societies, is a pathologically and clinica
Sleep disturbances and dementia.
Cipriani G, Lucetti C, Danti S, Nuti A. Cipriani G, et al. Psychogeriatrics. 2015 Mar;15(1):65-74. doi: 10.1111/psyg.12069. Epub 2014 Dec 16. Psychogeriatrics. 2015. PMID: 25515641 Review.
The magnitude of disordered sleep among individuals affected by dementia has been clearly demonstrated, and disturbed sleep is a major clinical problem in dementia. Comorbid insomnia and other sleep disturbances are common in patients with neurodegenerative disorder …
The magnitude of disordered sleep among individuals affected by dementia has been clearly demonstrated, and disturbed sleep is a majo …
Sleep and Alzheimer's disease.
Peter-Derex L, Yammine P, Bastuji H, Croisile B. Peter-Derex L, et al. Sleep Med Rev. 2015 Feb;19:29-38. doi: 10.1016/j.smrv.2014.03.007. Epub 2014 Apr 3. Sleep Med Rev. 2015. PMID: 24846773 Review.
Sleep disorders are frequent in Alzheimer's disease (AD), with a significant impact on patients and caregivers and a major risk factor for early institutionalization. ...
Sleep disorders are frequent in Alzheimer's disease (AD), with a significant impact on patients and caregivers and a ma …
[Alzheimer's disease].
Yilmaz U. Yilmaz U. Radiologe. 2015 May;55(5):386-8. doi: 10.1007/s00117-014-2796-2. Radiologe. 2015. PMID: 25957008 Free article. German.
Alzheimer's disease is a progressive neurodegenerative disorder with characteristic neuropathological changes. ...In addition to the articles in this issue that focus on the imaging of dementia, this article provides a brief overview of clinically rele
Alzheimer's disease is a progressive neurodegenerative disorder with characteristic neuropathological changes. ...In ad
Stress, Meditation, and Alzheimer's Disease Prevention: Where The Evidence Stands.
Khalsa DS. Khalsa DS. J Alzheimers Dis. 2015;48(1):1-12. doi: 10.3233/JAD-142766. J Alzheimers Dis. 2015. PMID: 26445019 Free PMC article. Review.
Mitigating the extensive negative biochemical effects of stress is a superficially discussed target of Alzheimer's disease (AD) prevention, yet may be critically important. This paper reviews lifestyle and stress as possible factors contributing to AD and med …
Mitigating the extensive negative biochemical effects of stress is a superficially discussed target of Alzheimer's disease
Early- and late-onset Alzheimer disease: Are they the same entity?
Tellechea P, Pujol N, Esteve-Belloch P, Echeveste B, García-Eulate MR, Arbizu J, Riverol M. Tellechea P, et al. Neurologia (Engl Ed). 2018 May;33(4):244-253. doi: 10.1016/j.nrl.2015.08.002. Epub 2015 Nov 3. Neurologia (Engl Ed). 2018. PMID: 26546285 Free article. Review. English, Spanish.
Early-onset Alzheimer disease (EOAD), which presents in patients younger than 65 years, has frequently been described as having different features from those of late-onset Alzheimer disease (LOAD). ...Fundamentally, the onset of EOAD is more likely to …
Early-onset Alzheimer disease (EOAD), which presents in patients younger than 65 years, has frequently been described as havin …
Exercise, cognitive function, and aging.
Barnes JN. Barnes JN. Adv Physiol Educ. 2015 Jun;39(2):55-62. doi: 10.1152/advan.00101.2014. Adv Physiol Educ. 2015. PMID: 26031719 Free PMC article. Review.
Increasing the lifespan of a population is often a marker of a country's success. With the percentage of the population over 65 yr of age expanding, managing the health and independence of this population is an ongoing concern. ...This review describes how aging is associa …
Increasing the lifespan of a population is often a marker of a country's success. With the percentage of the population over 65 yr of …
Rodent models for Alzheimer's disease drug discovery.
Puzzo D, Gulisano W, Palmeri A, Arancio O. Puzzo D, et al. Expert Opin Drug Discov. 2015 Jul;10(7):703-11. doi: 10.1517/17460441.2015.1041913. Epub 2015 Apr 30. Expert Opin Drug Discov. 2015. PMID: 25927677 Free PMC article. Review.
INTRODUCTION: Alzheimer's disease (AD) is a neurodegenerative disorder characterized by memory loss and personality changes, leading to dementia. Histopathological hallmarks are represented by aggregates of beta-amyloid peptide (Abeta) in senile plaque …
INTRODUCTION: Alzheimer's disease (AD) is a neurodegenerative disorder characterized by memory loss and personality cha …
Working memory and executive function decline across normal aging, mild cognitive impairment, and Alzheimer's disease.
Kirova AM, Bays RB, Lagalwar S. Kirova AM, et al. Biomed Res Int. 2015;2015:748212. doi: 10.1155/2015/748212. Epub 2015 Oct 15. Biomed Res Int. 2015. PMID: 26550575 Free PMC article. Review.
Alzheimer's disease (AD) is a progressive neurodegenerative disease marked by deficits in episodic memory, working memory (WM), and executive function. Examples of executive dysfunction in AD include poor selective and divided attention, failed inhibit
Alzheimer's disease (AD) is a progressive neurodegenerative disease marked by deficits in episodic memory, worki
Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease.
Nelson AR, Sweeney MD, Sagare AP, Zlokovic BV. Nelson AR, et al. Biochim Biophys Acta. 2016 May;1862(5):887-900. doi: 10.1016/j.bbadis.2015.12.016. Epub 2015 Dec 17. Biochim Biophys Acta. 2016. PMID: 26705676 Free PMC article. Review.
Vascular insults can initiate a cascade of molecular events leading to neurodegeneration, cognitive impairment, and dementia. Here, we review the cellular and molecular mechanisms in cerebral blood vessels and the pathophysiological events leading to cerebral blood flow dy …
Vascular insults can initiate a cascade of molecular events leading to neurodegeneration, cognitive impairment, and dementia. Here, w …
15,877 results
You have reached the last available page of results. Please see the User Guide for more information.